Anonymous
Guest
Anonymous
Guest
If they are not canned its game over for Depuy.
She's never had to because all the upper manage MEN t all seem to reeeaaallly like her. I remember once over hearing Kilburn telling her what an awesome job she had done. All the ego stroking is what part of what has happened to DePuy Warsaw. Like the other posts said, a former casting PD- Kilburn and a Canadian Sales rep that couldn't cut the mustard- Eldahl are the leaders? In 2000 Ekdahl was only a lil ole Product Director. How the hell did he qualify for president? I must be blind.
If they are not canned its game over for Depuy.
My sense is that they keep all three in place and blame others.
Unless JnJ set him up as the fall guy. Takes someone with little brains to manipulate.
We are forever known as that, unethical.
JNJ is " family" company...they hit that one on the head. This is how this company feels about patients.
A New Jersey jury heard a readback of testimony by a woman who is suing Johnson & Johnson (JNJ)’s Ethicon unit over claims the company defectively designed her vaginal mesh implant and failed to warn her properly of the risks.
Jurors today reheard the testimony of Linda Gross, 47, a South Dakota nurse whose lawsuit is the first of 1,800 to go to trial over claims that Ethicon’s Gynecare Prolift injured women. The panel of six women and three men has deliberated for three days in state court in Atlantic City without a verdict.
Gross had 18 operations after her mesh was implanted on July 13, 2006, to shore up pelvic muscles. She said her life has changed dramatically for the worse. She said she is in constant pain and can no longer sit comfortably. She has prescriptions for 20 different medicines to help with her pelvic problems.
“Who you see standing here now is not who I was,” Gross told jurors on Jan. 31 in testimony read by a court reporter from a transcript. “I was eager and energetic, loved to go to work, loved to participate in church activities, school activities.”
J&J, the world’s biggest seller of health-care products, claims the Prolift is safe and effective, and it warned of the risks. In August, J&J stopped selling four mesh devices in the U.S., including the Prolift. The company, based in New Brunswick, New Jersey, said in June that it would end sales worldwide because of the products’ lack of commercial viability, and not based on their safety and effectiveness.